Plasma cystatin-C and risk of developing gestational diabetes mellitus

Diabetes and Metabolic Syndrome: Clinical Research and Reviews

Volumn 8, Issue 1, 2014, Pages 33-35

  Yousefzadeh, Gholamreza ^a   Pezeshki, Sara ^a   Gholamhosseinian, Ahmad ^a   Nazemzadeh, Mahsa ^a   Shokoohi, Mostafa ^b  

^a KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cystatin C; Gestational diabetes; Pregnancy

Indexed keywords

CHOLESTEROL; CREATININE; CYSTATIN C; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; UREA;

ADULT; ARTICLE; BLOOD ANALYSIS; BODY MASS; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CYSTATIN C BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION STUDY; FEMALE; GESTATIONAL AGE; GLUCOSE BLOOD LEVEL; HUMAN; INFLAMMATION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MATERNAL AGE; NEUROLOGIC DISEASE; ORAL GLUCOSE TOLERANCE TEST; PARITY; PATIENT MONITORING; PREDICTION; PREGNANCY DIABETES MELLITUS; PREGNANT WOMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; UREA BLOOD LEVEL;

CYSTATIN-C; GESTATIONAL DIABETES; PREGNANCY;

BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CYSTATIN C; DIABETES, GESTATIONAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GESTATIONAL AGE; HUMANS; IRAN; LINEAR MODELS; PREGNANCY;

EID: 84897105701     PISSN: 18714021     EISSN: 18780334     Source Type: Journal    
DOI: 10.1016/j.dsx.2013.10.016     Document Type: Article

References (28)

1. Zerovnik E. The emerging role of cystatins in Alzheimer's disease. Bioessays 2009;31(June (6)):597-9.
2. Ghidoni R, Benussi L, Glionna M, Desenzani S, Albertini V, Levy E, et al. Plasma cystatin C and risk of developing Alzheimer's disease in subjects with mild cognitive impairment. J Alzheimers Dis 2010;22(3):985-91.
3. Dupont M, Wu Y, Hazen SL, Tang WH. Cystatin C identifies patients with stable chronic heart failure at increased risk for adverse cardiovascular events. Circ Heart Fail 2012;5(September (5)):602-9 [Epub 16.08.12].
4. Meng L, Yang Y, Qi LT, Wang XJ, Xu GB, Zhang BW. Elevated serum cystatin C is an independent predictor of cardiovascular events in people with relatively normal renal function. J Nephrol 2012;25(May-June (3)):426-30.
5. Ohara G, Miyazaki K, Kurishima K, Kagohashi K, Ishikawa H, Satoh H, et al. Serum levels of cystatin C in elderly lung cancer patients. Oncol Lett 2012;3(February (2)):303-6.
6. Nückel H, Langer C, Herget-Rosenthal S, Wichert M, Assert R, Döhner H, et al. Prognostic significance of serum cystatin C in multiple myeloma. Int J Hematol 2012;95(May (5)):545-50.
7. Rasouli HA, Moghadam MM, Tabatabaiefar M, Taslimi F, Sheybani KM, Alidoosti A, et al. Comparing cystatin C changes as a measure of renal function before and after radiotherapy in patients with stomach cancer. Acta Med Iran 2012;50(1):43-6.
8. Ozden TA, Tekerek H, Baş F, Darendeliler F. Effect of hypo-and euthyroid status on serum cystatin C levels. J Clin Res Pediatr Endocrinol 2010;2(4):155-8.
9. Kotajima N, Yanagawa Y, Aoki T, Tsunekawa K, Morimura T, Ogiwara T, et al. Influence of thyroid hormones and transforming growth factor-b1 on cystatin C concentrations. J Int Med Res 2010;38(July-August (4)):1365-73.
10. Wiesli P, Schwegler B, Spinas GA, Schmid C. Serum cystatin C is sensitive to small changes in thyroid function. Clin Chim Acta 2003;338(December (1-2)):87-90.
11. Silva MV, Moscoso Solorzano G, Nishida SK, Kirsztajn GM. Are serum cystatin C levels influenced by steroid doses in lupus nephritis patients? J Bras Nefrol 2011;33(July-September (3)):306-12.
12. Risch L, Herklotz R, Blumberg A, Huber AR. Effects of glucocorticoid immunosuppression on serum cystatin C concentrations in renal transplant patients. Clin Chem 2001;47(November (11)):2055-9.
13. Cimerman N, Brguljan PM, Krasovec M, Suskovic S, Kos J. Serum cystatin C, a potent inhibitor of cysteine proteinases, is elevated in asthmatic patients. Clin Chim Acta 2000;300(October (1-2)):83-95.
14. Gagneux-Brunon A, Mariat C, Delanaye P. Cystatin C in HIV-infected patients: promising but not yet ready for prime time. Nephrol Dial Transplant 2012;27(April (4)):1305-13.
15. Overton ET, Patel P, Mondy K, Bush T, Conley L, Rhame F, et al., Sun Study Investigators. Cystatin C and baseline renal function among HIV-infected persons in the SUN Study. AIDS Res Hum Retroviruses 2012;28(February (2)):148-55.
16. Samouilidou EC, Grapsa E. Relationship of serum cystatin C with C-reactive protein and apolipoprotein A1 in patients on hemodialysis. Ren Fail 2008;30(7):711-5.
17. Donahue RP, Stranges S, Rejman K, Rafalson LB, Dmochowski J, Trevisan M. Elevated cystatin C concentration and progression to pre-diabetes: the Western New York study. Diabetes Care 2007;30(July (7)):1724-9 [Epub 24.04.07].
18. Suzuki Y, Matsushita K, Seimiya M, Yoshida T, Sawabe Y, Ogawa M, et al. Serum cystatin C as a marker for early detection of chronic kidney disease and grade 2 nephropathy in Japanese patients with type 2 diabetes. Clin Chem Lab Med 2012;50(October (10)):1833-9. http://dx.doi.org/10.1515/cclm-2011-0777.
19. Dhia RB, Hellara I, Harzallah O, Neffati F, Khochtali I, Mahjoub S, et al. Evaluation of the renal function in type 2 diabetes: clearance calculation or cystatin C? Ann Biol Clin (Paris) 2012;70(May-June (3)):287-94. http://dx.doi.org/10.1684/abc.2012.0702.
20. Qing X, Furong W, Yunxia L, Jian Z, Xuping W, Ling G. Cystatin C and asymptomatic coronary artery disease in patients with metabolic syndrome and normal glomerular filtration rate. Cardiovasc Diabetol 2012;11(September):108.
21. Babay Z, Al-Wakeel J, Addar M, Mittwalli A, Tarif N, Hammad D, et al. Serum cystatin C in pregnant women: reference values, reliable and superior diagnostic accuracy. Clin Exp Obstet Gynecol 2005;32(3):175-9. (Pubitemid 41687759)
22. Franceschini N, Qiu C, Barrow DA, Williams MA. Cystatin C and preeclampsia: a case-control study. Ren Fail 2008;30(1):89-95.
23. Strevens H, Wide-Swensson D, Torffvit O, Grubb A. Serum cystatin C for assessment of glomerular filtration rate in pregnant and non-pregnant women. Indications of altered filtration process in pregnancy. Scand J Clin Lab Invest 2002;62(2):141-7. (Pubitemid 34407551)
24. Akbari A, Lepage N, Keely E, Clark HD, Jaffey J, MacKinnon M, et al. Cystatin-C and beta trace protein as markers of renal function in pregnancy. BJOG 2005;112(May (5)):575-8.
25. Qing O, Jian L, Qing-feng S, Yi-ping L, Yu-chun W, Xi-fang T. Clinical significance of cystatin C and uromicroproteins in evaluation of renal function of gestational diabetes mellitus patients. Shandong Med 2011;28.
26. Surendar J, Indulekha K, Aravindhan V, Ganesan A, Mohan V. Association of Cystatin-C with metabolic syndrome in normal glucose-tolerant subjects (CURES-97). Diabetes Technol Ther 2010;12(November (11)):907-12.
27. Yokoyama H, Inoue T, Node K. Effect of insulin-unstimulated diabetic therapy with miglitol on serum cystatin C level and its clinical significance. Diabetes Res Clin Pract 2009;83(January (1)):77-82. http://dx.doi.org/10.1016/j. diabres.2008.09.049.
28. Lee SH, Park SA, Ko SH, Yim HW, Ahn YB, Yoon KH, et al. Insulin resistance and inflammation may have an additional role in the link between cystatin C and cardiovascular disease in type 2 diabetes mellitus patients. Metabolism 2010;59(February (2)):241-6.